中文名稱  磷酸化急性髓細(xì)胞1蛋白抗體說(shuō)明書 

英文名稱  Anti-phospho-RUNX1/AML1(Ser249)

別    名 RUNX1 (phospho-Ser249); p-RUNX1 (Ser249); RUNX1 (phospho S249); RUNX1 (phospho Ser249); Acute myeloid leukemia 1; Acute myeloid leukemia 1 protein; alpha subunit core binding factor; AML 1; AML1 EVI 1; Aml1 oncogene; AMLCR 1; AMLCR1; CBFA 2; CBFA2; Core binding factor alpha 2 subunit; Core binding factor runt domain alpha subunit 2; EVI 1; EVI1; HGNC; Oncogene AML 1; PEA2 alpha; PEBP2 alpha B; PEBP2A2; PEBP2aB; Polyomavirus enhancer binding protein 2 alpha B subunit; Run1; Runt related transcription factor 1; RUNX 1; SL3 3 enhancer factor 1 alpha B subunit; SL3/AKV core binding factor alpha B subunit; RUNX1_HUMAN.

產(chǎn)品屬性：

磷酸化急性髓細(xì)胞1蛋白抗體說(shuō)明書 濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來(lái)源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Guinea Pig

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域     細(xì)胞生物 細(xì)胞凋亡

蛋白分子量  predicted molecular weight: 50kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthesised phosphopeptide derived from human RUNX1 around the phosphorylation site of Ser249 [QP(p-S)PP]

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

磷酸化急性髓細(xì)胞1蛋白抗體說(shuō)明書 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 AML1/Runx1 binds DNA as a monomer and through the Runt domain. DNA binding is increased by heterodimerization with CBFB. Isoform AML1L can neither bind DNA nor heterodimerize and interferes with the transactivation activity of AML1/Runx1. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T cell receptor enhancers, LCK, IL3 and GMCSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. AML1/Runx1 is expressed in a wide variety of tissues and is expressed at the highest levels in thymus, bone marrow and peripheral blood. Defects in AML1/Runx1 are the cause of familial platelet disorder with associated myeloid malignancy, an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia.

Function : CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Isoform AML-1L interferes with the transactivation activity of RUNX1. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the mouse BLK promoter. Inhibits KAT6B-dependent transcriptional activation.

Subunit : Heterodimer with CBFB. RUNX1 binds DNA as a monomer and through the Runt domain. DNA-binding is increased by heterodimerization. Isoform AML-1L can neither bind DNA nor heterodimerize. Interacts with TLE1 and ALYREF/THOC4. Interacts with ELF1, ELF2 and SPI1. Interacts via its Runt domain with the ELF4 N-terminal region. Interaction with ELF2 isoform 2 (NERF-1a) may act to repress RUNX1-mediated transactivation. Interacts with KAT6A and KAT6B. Interacts with SUV39H1, leading to abrogation of transactivating and DNA-binding properties of RUNX1. Interacts with YAP1. Interacts with HIPK2 (By similarity). Interaction with CDK6 prevents myeloid differentiation, reducing its transcription transactivation activity.

Subcellular Location : Nucleus.

Tissue Specificity : Expressed in all tissues examined except brain and heart. Highest levels in thymus, bone marrow and peripheral blood.

Post-translational modifications : Phosphorylated in its C-terminus upon IL-6 treatment. Phosphorylation enhances interaction with KAT6A.

Methylated.

Phosphorylated in Ser-249 Thr-273 and Ser-276 by HIPK2 when associated with CBFB and DNA. This phosphorylation promotes subsequent EP300 phosphorylation.

DISEASE : Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with EAP or MECOM.

Note=A chromosomal aberration involving RUNX1/AML1 is found in childhood acute lymphoblastic leukemia (ALL). Translocation t(12;21)(p13;q22) with TEL. The translocation fuses the 3'-end of TEL to the alternate 5'-exon of AML-1H.

Note=A chromosomal aberration involving RUNX1 is found in acute leukemia. Translocation t(11,21)(q13;q22) that forms a MACROD1-RUNX1 fusion protein.

Defects in RUNX1 are the cause of familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399]. FPDMM is an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia.

Note=A chromosomal aberration involving RUNX1/AML1 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein.

Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelomonocytic leukemia. Inversion inv(21)(q21;q22) with USP16.

Similarity : Contains 1 Runt domain.

Database links : UniProtKB/Swiss-Prot: Q01196.3

實(shí)驗(yàn)流程：

全、新、優(yōu)、品、好四大特點(diǎn)：

磷酸化急性髓細(xì)胞1蛋白抗體說(shuō)明書 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。

技術(shù)外包服務(wù):

★磷酸化急性髓細(xì)胞1蛋白抗體說(shuō)明書 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

正在熱銷的相關(guān)產(chǎn)品：

GnRHR peptide 激素釋放激素受體抗原Multi-class antibodies規(guī)格： 0.5mg

PPM1A PPM1A / PP2C-alpha 鼠單抗 (FITC) Human

Rhesus antibody Rh Phospho-CRMP2 (Thr514+Ser518) 磷酸化二氫嘧啶酶樣2抗體 規(guī)格 0.1ml

Foline-Phenol(福林酚),2N 50ml/500ml 自產(chǎn)

ZFP36L1 英文名稱： EGF應(yīng)答因子1抗體抗體 0.2ml

DRGX 英文名稱： 背根神經(jīng)節(jié)同源蛋白DRGX抗體 0.2ml

PPM1A PPM1A / PP2C-alpha 鼠單抗 (FITC) Human

Anti-PTGEs/FITC 熒光素標(biāo)記素E合成酶抗體IgGMulti-class antibodies規(guī)格： 0.2ml

THY (thyroglobulin,TG) 甲狀腺球蛋白Multi-class antibodies規(guī)格： 10mg

胰島素受體底物-4抗體 Anti-IRS-4 0.2ml

Goat anti-Mouse IgM whole serum 羊抗小鼠IgM抗血清 1ml

Ferritin Light Chain 英文名稱： 鐵蛋白輕鏈抗體 0.1ml

Rhesus antibody Rh phospho-PRKAB1(Ser182) 磷酸化腺苷單磷酸活化蛋白激酶β1抗體 規(guī)格 0.1ml

THY (thyroglobulin,TG) 甲狀腺球蛋白Multi-class antibodies規(guī)格： 10mg

SLC25A20 英文名稱： 線粒體二羧酸載體蛋白20抗體 0.1ml

EYA3 英文名稱： EYA3蛋白抗體 0.2ml

神經(jīng)絲蛋白抗體(人) Anti-AD7C-NTP/NTP/AF human 0.1ml

Anti-NHE1/RBITC 紅色羅丹明標(biāo)記氫通道蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Phospho-FGFR1 (Tyr307) 磷酸化堿性成纖維細(xì)胞生長(zhǎng)因子受體1抗體 規(guī)格 0.1ml

cRaf/Raf1(c-raf 1) cRaf/Raf1抗原Multi-class antibodies規(guī)格： 0.5mg

其他細(xì)胞因子

JeKo-1 人套細(xì)胞細(xì)胞

IFNA4 Others Mouse 小鼠 IFNA4 / Ierferon alpha-4 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

22RV1人細(xì)胞 Human prostate cancer 22RV1 cells 人

家貓腎細(xì)胞;CATK1

小鼠海馬趾神經(jīng)細(xì)胞(MH-h)(1×106) HCT116, 人結(jié)細(xì)胞 Human

CL-0350Hela S3(人細(xì)胞)5×106cells/瓶×2

EPHB2 Others Human 人 EphB2 / Hek5 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

人總RNAHPF NA

Hs-578T細(xì)胞，人癌細(xì)胞 SD大鼠骨髓間充質(zhì)干細(xì)胞,SDBMSC細(xì)胞 Hep-2, 人細(xì)胞系

NCI-H661(人大細(xì)胞細(xì)胞) 5×106cells/瓶×2

HDBEC Pellet 人皮膚內(nèi)皮細(xì)胞團(tuán)塊(少年者) > 1 mio.cells 前脂肪細(xì)胞培養(yǎng)基PAM-prf

磷酸化急性髓細(xì)胞1蛋白抗體說(shuō)明書 其他細(xì)胞因子

JeKo-1 人套細(xì)胞細(xì)胞

IFNA4 Others Mouse 小鼠 IFNA4 / Ierferon alpha-4 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

22RV1人細(xì)胞 Human prostate cancer 22RV1 cells 人

家貓腎細(xì)胞;CATK1

小鼠海馬趾神經(jīng)細(xì)胞(MH-h)(1×106) HCT116, 人結(jié)細(xì)胞 Human